Concomitant use of imatinib and warfarin in chronic phase chronic myeloid leukemia patients does not interfere with drug efficacy

被引：4
|
作者：
Breccia, Massimo [1 ]
Santopietro, Michelina [1 ]
Loglisci, Giuseppina [1 ]
Stagno, Fabio [2 ,3 ]
Cannella, Laura [1 ]
Carmosino, Ida [1 ]
Alimena, Giuliana [1 ]
机构：
[1] Dept Human Biotechnol & Hematol, I-00161 Rome, Italy
[2] Univ Catania, Dept Biomed Sci, Hematol Sect, Catania, Italy
[3] Univ Catania, Gen Pathol Sect, Catania, Italy
来源：
LEUKEMIA RESEARCH | 2010年 / 34卷 / 08期
关键词：
Chronic myeloid leukemia; Imatinib; Warfarin;
D O I：
10.1016/j.leukres.2010.03.015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E224 / E225
页数：2
相关论文
共 50 条
  • [21] Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy
    Bonifacio, Massimiliano
    Scaffidi, Luigi
    Binotto, Gianni
    Miggiano, Maria Cristina
    Danini, Marco
    Minotto, Claudia
    Griguolo, Davide
    Marin, Luciana
    Frison, Luca
    D'Amore, Fabio
    Basso, Marco
    Sartori, Roberto
    Tinelli, Martina
    Stulle, Manuela
    Fortuna, Stefania
    Bonalumi, Angela
    Bertoldero, Giovanni
    De Biasi, Ercole
    Ruggeri, Marco
    Semenzato, Gianpietro
    Fanin, Renato
    Pizzolo, Giovanni
    Krampera, Mauro
    Tiribelli, Mario
    LEUKEMIA RESEARCH, 2018, 74 : 75 - 79
  • [22] Imatinib dose optimization based on therapeutic drug monitoring in Chinese patients with chronic-phase chronic myeloid leukemia
    Cheng, Fang
    Zeng, Fang
    Li, Qiang
    Cui, Zheng
    Chen, Yilin
    Li, Weiming
    Zhang, Yu
    CANCER, 2022, 128 (22) : 3951 - 3958
  • [23] DASATINIB TREATMENT OF IMATINIB-RESISTANT AND IMATINIB-INTOLERANT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN A CHRONIC PHASE
    Vinogradova, O. Yu.
    Turkina, A. G.
    Vorontsova, A. V.
    Chelysheva, E. Yu.
    Gusarova, G. A.
    Kuznetsov, S. V.
    Goryacheva, S. R.
    Sokolova, M. A.
    Abakumov, E. M.
    Stakhina, O. V.
    Domracheva, E. V.
    Misyurin, A. V.
    Khoroshko, N. D.
    TERAPEVTICHESKII ARKHIV, 2009, 81 (07) : 41 - 46
  • [24] Imatinib Cessation in Children and Adolescents With Chronic Myeloid Leukemia in Chronic Phase
    Millot, Frederic
    Claviez, Alexander
    Leverger, Guy
    Corbaciglu, Selim
    Groll, Andreas H.
    Suttorp, Meinolf
    PEDIATRIC BLOOD & CANCER, 2014, 61 (02) : 355 - 357
  • [25] Cutaneous manifestations in chronic myeloid leukemia in chronic phase treated with imatinib
    Khokar, Abbas
    Malik, Uzma
    Butt, Ghazala
    Naumeri, Fatima
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2019, 58 (09) : 1098 - 1101
  • [26] Response to imatinib mesylate in childhood chronic myeloid leukemia in chronic phase
    Linga, Vijay Gandhi
    Ganta, Ranga Raman
    Kalpathi, Krishnamani Iyer
    Gundeti, Sadashivudu
    Rajappa, Senthil J.
    Digumarti, Raghunadharao
    Paul, Tara Roshni
    Tandon, Ashwani
    SOUTH ASIAN JOURNAL OF CANCER, 2014, 3 (04) : 203 - 205
  • [27] Response to imatinib mesylate in late chronic phase chronic myeloid leukemia
    Mukhopadhyay, S.
    Chitalkar, P. G.
    Gupta, P. R.
    Roy, U.
    Mukhopadhyay, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 40 - 41
  • [28] Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: Results of a Japanese phase II clinical study
    Morishima, Y
    Ogura, M
    Nishimura, M
    Yazaki, F
    Bessho, M
    Mizoguchi, H
    Chiba, S
    Hirai, H
    Tauchi, T
    Urabe, A
    Takahashi, M
    Ohnishi, K
    Yokozawa, T
    Emi, N
    Hirano, M
    Shimazaki, C
    Nakao, S
    Kawai, Y
    Fujimoto, M
    Taguchi, H
    Jinnai, I
    Ohno, R
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 80 (03) : 261 - 266
  • [29] Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia: Results of a Japanese Phase II Clinical Study
    Yasuo Morishima
    Michinori Ogura
    Miki Nishimura
    Fumiharu Yazaki
    Masami Bessho
    Hideaki Mizoguchi
    Shigeru Chiba
    Hisamaru Hirai
    Tetsuzo Tauchi
    Akio Urabe
    Masatomo Takahashi
    Kazunori Ohnishi
    Toshiya Yokozawa
    Nobuhiko Emi
    Masami Hirano
    Chihiro Shimazaki
    Shinji Nakao
    Yasukazu Kawai
    Masahiro Fujimoto
    Hirokuni Taguchi
    Itsuro Jinnai
    Ryuzo Ohno
    International Journal of Hematology, 2004, 80 : 261 - 266
  • [30] Platelet Dysfunction in Patients with Chronic Myeloid Leukemia: Does Imatinib Mesylate Improve It?
    Akay, Olga Meltem
    Mutlu, Fezan
    Gulbas, Zafer
    TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (02) : 127 - 130
12345